Moleculin Biotech (MBRX) Institutional Ownership $2.63 +0.13 (+5.20%) (As of 12/6/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Moleculin Biotech (NASDAQ:MBRX)CurrentInstitutional OwnershipPercentage15.52%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$41.97MNumber ofInstitutional Sellers(last 12 months)0 Get MBRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Moleculin Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MBRX Institutional Buying and Selling by Quarter Ad Porter & CompanyFirst JFK… next Elon?Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. Moleculin Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC156,000$549K0.0%+5.1%6.747% 2/13/2024 Armistice Capital LLC3,207,417$2.75M0.0%N/A9.600% 1/17/2024 Atticus Wealth Management LLC50,001$43K0.0%N/A0.168% 5/15/2023 Sio Capital Management LLC1,010,956$971K0.5%-2.5%3.407% 7/25/2022 Walker Asset Management LLC20,708$32K0.0%N/A0.072% 4/20/2022 Sigma Planning Corp57,500$102K0.0%+33.7%0.201% Get the Latest News and Ratings for MBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Moleculin Biotech and its competitors with MarketBeat's FREE daily newsletter. 2/2/2022 Sigma Planning Corp43,000$80K0.0%N/A0.150% 11/9/2021BlackRock Inc.270,402$812K0.0%-2.5%0.947% 9/17/2021 Virtu Financial LLC25,302$93K0.0%N/A0.089% 8/16/2021 Occudo Quantitative Strategies LP29,188$107K0.0%+31.7%0.102% 8/16/2021 State Street Corp59,900$220K0.0%N/A0.210% 8/13/2021 Geode Capital Management LLC237,586$871K0.0%+35.9%0.835% 8/13/2021 Vanguard Group Inc.1,047,529$3.84M0.0%+123.6%3.683% 8/12/2021 XTX Topco Ltd32,997$121K0.0%N/A0.116% 8/5/2021 GSA Capital Partners LLP31,120$114K0.0%N/A0.109% 5/21/2021 Citadel Advisors LLC13,843$56K0.0%N/A0.049% 5/19/2021 Squarepoint Ops LLC28,904$118K0.0%+134.2%0.102% 5/18/2021 Cubist Systematic Strategies LLC26,624$109K0.0%N/A0.094% 5/18/2021 Citadel Advisors LLC13,843$56K0.0%N/A0.049% 5/14/2021 Occudo Quantitative Strategies LP22,158$90K0.0%N/A0.078% 5/12/2021 Northern Trust Corp50,731$207K0.0%-43.1%0.178% 5/12/2021 Geode Capital Management LLC174,822$713K0.0%-40.6%0.615% 5/7/2021BlackRock Inc.239,326$977K0.0%+449.7%0.841% 4/27/2021 Harel Insurance Investments & Financial Services Ltd.10,000$136K0.0%N/A0.035% 4/14/2021 Taylor Cottrill Erickson & Associates Inc.16,964$69K0.0%-83.3%0.060% 2/10/2021 Renaissance Technologies LLC948,503$756K0.0%+6.4%7.901% 11/13/2020 Truist Financial Corp175,000$142K0.0%+25.0%0.284% (Data available from 1/1/2016 forward) MBRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MBRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Moleculin Biotech shares: Sio Capital Management LLC ($971K), and Armistice Capital LLC ($549K), Atticus Wealth Management LLC ($43K).Learn more on MBRX's institutional investors. What percentage of Moleculin Biotech stock is owned by institutional investors? 15.52% of Moleculin Biotech stock is owned by institutional investors. Learn more on MBRX's institutional investor holdings. Which institutional investors have been buying Moleculin Biotech stock? The following institutional investors have purchased Moleculin Biotech stock in the last 24 months: Armistice Capital LLC ($3.21M), and Atticus Wealth Management LLC ($50.00K). How much institutional buying is happening at Moleculin Biotech? Institutional investors have bought a total of 3,264,923 shares in the last 24 months. This purchase volume represents approximately $41.97M in transactions. Which Moleculin Biotech major shareholders have been selling company stock? The following institutional investors have sold Moleculin Biotech stock in the last 24 months: Sio Capital Management LLC ($25.90K). How much institutional selling is happening at Moleculin Biotech? Institutional investors have sold a total of 25,897 shares in the last 24 months. This volume of shares sold represents approximately $372.92K in transactions. Related Companies KALA Institutional Ownership MRKR Institutional Ownership IXHL Institutional Ownership LGVN Institutional Ownership PMN Institutional Ownership PLUR Institutional Ownership DARE Institutional Ownership LSB Institutional Ownership INKT Institutional Ownership RNXT Institutional Ownership This page (NASDAQ:MBRX) was last updated on 12/7/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Bold Move Could Change the Market ForeverAmerica’s Return to Gold? New economic vision could reshape your entire retirement strategy… Gold Safe Exchange | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moleculin Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moleculin Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MBRX Stock Alerts